You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 018716


✉ Email this page to a colleague

« Back to Dashboard


NDA 018716 describes TRANDATE, which is a drug marketed by Sebela Ireland Ltd, Alvogen, and Glaxosmithkline, and is included in three NDAs. Additional details are available on the TRANDATE profile page.

The generic ingredient in TRANDATE is hydrochlorothiazide; labetalol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.
Summary for 018716
Tradename:TRANDATE
Applicant:Alvogen
Ingredient:labetalol hydrochloride
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:May 24, 1985TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Aug 1, 1984TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Aug 1, 1984TE:RLD:Yes

Expired US Patents for NDA 018716

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 ⤷  Sign Up ⤷  Sign Up
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 ⤷  Sign Up ⤷  Sign Up
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-004 Aug 1, 1984 ⤷  Sign Up ⤷  Sign Up
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 ⤷  Sign Up ⤷  Sign Up
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 ⤷  Sign Up ⤷  Sign Up
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.